Clinical, Laboratory, and Bone Marrow Findings of 31 Patients With Waldenström Macroglobulinemia
Open Access
- 1 May 2020
- journal article
- research article
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 40 (3), 193-200
- https://doi.org/10.3343/alm.2020.40.3.193
Abstract
Ahn A, et al. Ann Lab Med. 2020 May;40(3):193-200. https://doi.org/10.3343/alm.2020.40.3.193Keywords
This publication has 32 references indexed in Scilit:
- XIII. Waldenström's macroglobulinaemia: an indolent B‐cell lymphoma with distinct molecular and clinical featuresHematological Oncology, 2013
- The Bone Marrow Microenvironment in Waldenström MacroglobulinemiaClinical Lymphoma Myeloma and Leukemia, 2013
- Immunophenotypic Differentiation Between Neoplastic Plasma Cells in Mature B-Cell Lymphoma vs Plasma Cell MyelomaAmerican Journal of Clinical Pathology, 2007
- Mast cells in Waldenstrom's macroglobulinemia support lymphoplasmacytic cell growth through CD154/CD40 signalingAnnals of Oncology, 2006
- Mast cells: the JEKYLL and HYDE of tumor growthTrends in Immunology, 2004
- Triclonal gammopathy in an extranodal non-Hodgkin lymphoma patientAmerican Journal of Hematology, 2003
- Mast cells and angiogenesisMicroscopy Research and Technique, 2002
- The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2mnull miceLeukemia, 2002
- Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells.JCI Insight, 1997
- Induction of human IgE synthesis in B cells by mast cells and basophilsNature, 1993